Login
Astrazeneca PLC (ADR) NYSE: AZN
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company.
| Name | Astrazeneca PLC (ADR) |
| Ticker | AZN |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Price | 52.61 |
| 52W Low/High | 37.79 / 61.10 |
| Market cap | 138 B |
| 1Y Total Return |
10.74%
Above Average |
| 1Y Volatility |
35.34%
Low Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company.
Details
| Ticker | AZN |
| Name | Astrazeneca PLC (ADR) |
| ISIN | |
| CUSIP | 046353108 |
| Exchange | NYSE |
| Sector | Health Care |
| Industry | Drug Manufacturers - Diversified |
| Country | Great Britain |
| Currency | U.S. Dollar |
Share as of 11/27/20
| Close Price | 52.61 |
| 52W Low/High | 37.79 / 61.10 |
| Market cap | 138 B |
| 1Y Total Return |
10.74%
Above Average |
| 1Y Volatility |
35.34%
Low Risk |
| Beta | 0.39 |
| PE (trailing) |
55.67
High |
| 12M Dividends | 1.4 |
| Last Dividend Date | 8/13/20 |
| Dividend Yield | 2.66% |
Fin. Strength
| Net Profit Margin | 9.3% |
| Cash from Op. / Cur. Liabilities | 0.23 |
| Diluted Earnings / Share | 0.95 |
| ROE | 19.8% |
| ROIC | 8.0% |
| Price / Revenue | 2.7 |
| Price / Book | 5.7 |
| Price / CF | 15.8 |
| Current Ratio | 1.0 |
| Cur.Liabilities / Tot.Liabilities | 0.4 |
| Financial Leverage | 1.83 |
| in Mils USD |
rolling-year up to September
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Revenue |
25,871
|
24,137
|
21,450
|
22,273
|
23,816
|
25,025
|
|
| Gross Profit |
20,719
|
18,957
|
16,926
|
18,020
|
19,581
|
19,981
|
|
| R&D |
6,363
|
5,980
|
5,471
|
5,749
|
6,093
|
5,750
|
|
| EBITDA |
8,320
|
7,237
|
6,252
|
8,090
|
5,968
|
6,013
|
|
| Operating Income |
4,252
|
3,424
|
2,996
|
5,524
|
3,457
|
2,677
|
|
| Net Income exc. Extra |
2,416
|
1,959
|
2,302
|
3,424
|
2,397
|
1,697
|
|
| per Share | |||||||
| Diluted avg Shares |
1,313
|
1,312
|
1,267
|
1,267
|
1,266
|
1,265
|
|
| EPS exc. Extra |
0.95
|
0.81
|
0.96
|
1.40
|
0.98
|
0.67
|
|
| Dividend |
1.40
|
1.40
|
1.40
|
1.40
|
1.40
|
2.35
|
|
| Div. Yield (an.) |
2.55%
|
3.14%
|
3.54%
|
4.13%
|
4.26%
|
7.39%
|
|
| Balance Sheet | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Total Assets |
64,112
|
58,906
|
61,443
|
64,587
|
63,172
|
54,118
|
|
| Cash, Eq & Invt ShortTerm |
8,446
|
4,780
|
4,228
|
5,211
|
3,999
|
4,577
|
|
| Total Current Assets |
18,166
|
13,520
|
13,108
|
13,634
|
12,866
|
13,199
|
|
| Total Non-Current Assets |
45,946
|
45,386
|
48,335
|
50,953
|
50,306
|
40,919
|
|
| Intangibles |
32,324
|
33,144
|
36,147
|
38,965
|
40,263
|
31,427
|
|
| Total Liabilities |
50,494
|
45,237
|
47,906
|
49,140
|
48,260
|
36,750
|
|
| Total Current Liabilities |
18,942
|
14,776
|
15,248
|
14,463
|
15,382
|
16,036
|
|
| Long Term Debt |
31,552
|
30,461
|
32,658
|
34,677
|
32,878
|
20,714
|
|
| Shareholder equity |
12,195
|
12,164
|
11,936
|
13,725
|
13,072
|
17,349
|
|
| Cash Flow | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Cash from Operations |
4,376
|
3,818
|
1,391
|
4,541
|
2,756
|
8,792
|
|
| Depreciation |
3,995
|
3,781
|
3,198
|
2,519
|
2,483
|
3,282
|
|
| Cash from Investing |
-365
|
212
|
-1,606
|
-83
|
-7,157
|
-7,032
|
|
| Capex |
845
|
943
|
1,167
|
1,291
|
1,288
|
854
|
|
| Cash from Financing |
13
|
-3,503
|
-324
|
-3,228
|
3,264
|
-2,705
|
|
| Stock Issued |
33
|
3,513
|
37
|
37
|
53
|
279
|
|
| Debt (LT) Issued |
3,653
|
-3,428
|
3,190
|
274
|
6,754
|
653
|
|
| Free Cash Flow |
8,787
|
5,559
|
5,990
|
3,834
|
5,515
|
7,184
|
|
| Ratios | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
| Net Profit Margin |
9.3%
|
8.1%
|
10.7%
|
15.4%
|
10.1%
|
6.8%
|
|
| NCFO / Op.Income |
102.9%
|
111.5%
|
46.4%
|
82.2%
|
79.7%
|
328.4%
|
|
| Current Ratio |
1.0
|
0.9
|
0.9
|
0.9
|
0.8
|
0.8
|
|
| Financial Leverage D/E |
1.83
|
1.49
|
1.75
|
1.30
|
1.35
|
0.63
|
|
| Return on Capital Avg |
8.0%
|
7.9%
|
8.0%
|
9.0%
|
10.0%
|
8.0%
|
|
| Return on Shareholder Equity |
19.8%
|
16.3%
|
17.9%
|
25.6%
|
15.8%
|
9.0%
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available